HF 4299 Summary

• Commissioner of human services must conduct a pilot project testing prescription digital therapeutics (PDTs) for treating substance use and opioid use disorders among medical assistance enrollees, with sites in the seven-county metropolitan area and greater Minnesota.

• Pilot project will serve up to 400 medical assistance enrollees for up to 12 weeks of PDT treatment in addition to medication and behavioral health services, with participation voluntary and requiring informed consent.

• Commissioner must submit a report by September 30, 2025 describing population characteristics, successes and challenges, effects on treatment access and patient satisfaction, hospitalization rate comparisons, and recommendations on whether PDTs should be covered under medical assistance.

• General fund appropriation in fiscal year 2023 is provided to establish and implement the pilot project, with up to a portion allowed for staffing and administrative costs, and funds expiring January 1, 2025.